𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer

✍ Scribed by Urata, Yoshiko; Okamoto, Isamu; Takeda, Masayuki; Hattori, Yoshihiro; Okuno, Keiko; Shimada, Temiko; Kurata, Takayasu; Kaneda, Hiroyasu; Miyazaki, Masaki; Terashima, Masaaki; Tanaka, Kaoru; Morita, Satoshi; Nakagawa, Kazuhiko; Negoro, Shunichi; Satouchi, Miyako

Book ID
120936038
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
125 KB
Volume
119
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

PointBreak: A Randomized Phase III Study
PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer
✍ Patel, J. D.; Socinski, M. A.; Garon, E. B.; Reynolds, C. H.; Spigel, D. R.; Ols πŸ“‚ Article πŸ“… 2013 πŸ› American Society of Clinical Oncology 🌐 English βš– 243 KB
Treatment Rationale and Study Design for
Treatment Rationale and Study Design for a Randomized Trial of Pemetrexed/Carboplatin Followed by Maintenance Pemetrexed Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients With Advanced Non–Small-Cell Lung Cancer of Nonsquamous Histology
✍ Ralph G. Zinner; Scott B. Saxman; Guangbin Peng; Matthew J. Monberg; Waldo I. Or πŸ“‚ Article πŸ“… 2010 πŸ› CIG Media Group, LP. 🌐 English βš– 122 KB
Treatment Rationale and Study Design for
Treatment Rationale and Study Design for the PointBreak Study: A Randomized, Open-label Phase III Study of Pemetrexed/Carboplatin/Bevacizumab Followed by Maintenance Pemetrexed/Bevacizumab Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer
✍ Jyoti D. Patel; Philip Bonomi; Mark A. Socinski; Ramaswamy Govindan; Shengyan Ho πŸ“‚ Article πŸ“… 2009 πŸ› CIG Media Group, LP. 🌐 English βš– 100 KB
Induction Pemetrexed and Cisplatin Follo
Induction Pemetrexed and Cisplatin Followed by Maintenance Pemetrexed Versus Carboplatin Plus Paclitaxel Plus Bevacizumab Followed by Maintenance Bevacizumab: A Quality of Life–Oriented Randomized Phase III Study in Patients With Advanced Non-Squamous Non–Small-Cell Lung Cancer (ERACLE)
✍ Domenico Galetta; Salvatore Pisconti; Saverio Cinieri; Giovanni Luigi Pappagallo πŸ“‚ Article πŸ“… 2011 πŸ› CIG Media Group, LP. 🌐 English βš– 235 KB